Senior insider sale
Chief Accounting Officer at KALARIS THERAPEUTICS, INC. — senior position signals high conviction
$2.5K
135.00 shares
What this filing means
HAGEN BRETT R plans to sell 135.00 shares of KALARIS THERAPEUTICS, INC. valued at approximately $2.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/24/2025ACC: 0000950170-25-008720
Officer· Chief Accounting Officer
Since Jul 2020
135.00
Shares to sell
$2.5K
Approx. market value
36.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock
N/A
1/23/2025
36.00Total acquired36.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2025 | Restricted Stock N/A | 36.00 | — |
| Total | 36.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
14.00
Market value
$146.00
1/10/2025
—Completed
Units to sell
13.00
Market value
$554.00
11/19/2024
—Completed
Units to sell
72.00
Market value
$1.4K
11/5/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
36.00
Market value
$341.00
1/23/2025
Total
Units
135.00
Value
$2.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/10/2025 | 14.00 | $146.00 | — | Completed |
11/19/2024 | 13.00 | $554.00 | — | Completed |
11/5/2024 | 72.00 | $1.4K | — | Completed |
| Planned — Approximate Date | ||||
1/23/2025 | 36.00 | $341.00 | NASDAQ | Planned |
| Total | 135.00 | $2.5K | ||